Related Experiment Video

Updated: Apr 16, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K

Targeted therapies in melanoma

Stergios J Moschos1, Ramya Pinnamaneni2

  • 1Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Physicians Office Building, Suite 3116-CB#7305, 170 Manning Drive, Chapel Hill, NC 27599, USA.

Surgical Oncology Clinics of North America
|March 15, 2015
PubMed

Insights

Understanding melanoma chemoresistance and genetic heterogeneity is key to developing new treatments. Combination therapies combining targeted drugs and immunotherapies may overcome drug resistance in melanoma.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Recent advances in melanoma biology have illuminated mechanisms of chemoresistance and genetic heterogeneity.
  • Progress in drug design has led to significant breakthroughs in melanoma treatment.

Purpose of the Study:

  • To explore the interplay between genetic aberrations and nongenetic changes in melanoma.
  • To identify strategies for overcoming drug resistance in melanoma treatment.

Main Methods:

  • Analysis of genetic aberrations in melanoma.
  • Investigation of nongenetic factors influencing treatment response.
  • Review of current targeted therapies and immunotherapies.

Main Results:

  • Targeted therapies offer clinical benefits but are associated with inherent drug resistance.
  • Understanding the complex interplay of genetic and nongenetic factors is crucial for future advances.
  • Combination therapies show promise in preventing the development of resistance.

Conclusions:

  • Future melanoma treatment advances depend on a comprehensive understanding of melanoma biology, including genetic and nongenetic factors.
  • Combination therapies, potentially involving small molecule inhibitors and immunotherapies, represent a promising strategy to combat melanoma chemoresistance.
Keywords:
BRAF inhibitorsImmunotherapiesMelanomaNext generation sequencingOcular melanoma

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
141
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K